Serum Concentrations of Myostatin and Myostatin-Interacting Proteins Do Not Differ Between Young and Sarcopenic Elderly Men
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Sarcopenia is the loss of muscle size and function during ageing. The aim of this study was to test whether serum concentrations of myostatin and interacting proteins (GASP-1, FLRG, and follistatin) differed between young and elderly sarcopenic men. Isometric knee extensor maximal voluntary contraction and quadriceps cross-sectional area (magnetic resonance imaging measurement) were significantly higher in young (22 ± 2 years; 266 ± 54 N/m; 8,686 ± 1,154 mm(2)) than in mildly sarcopenic (69 ± 3 years; 183 ± 17 N/m; 6,621±718 mm(2)) and severely sarcopenic men (76 ± 6 years; 127 ± 23 N/m; 5,846 ± 591 mm(2)), respectively (p ≤ .01 for all comparisons). There was a trend (p = .06) toward higher FLRG in young (20 ± 8 ng/mL) than in mildly (15 ± 6 ng/mL) and severely sarcopenic men (17 ± 8 ng/mL). Myostatin, follistatin, GASP-1, tumor necrosis factor α, and interleukin-6 did not differ significantly. Insulin-like growth factor-1 and free testosterone were both significantly lower in sarcopenic men (p < .001). This suggests that altered serum concentrations of myostatin and myostatin-interacting proteins are not contributing to sarcopenia with the possible exception of FLRG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“Criteria that have been proposed to identify or diagnose sarcopenia are the ratio of appendicular skeletal muscle mass relative to height (11) or the knee extension strength/torque, handgrip strength, or calf muscle area at least 2 SDs below the mean of a young reference group (12).”
BackgroundSarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 1×
“620 “SARCOPENIA ” is defined as the loss of muscle mass and function that occurs during normal ageing (1,2).”
BackgroundLauretani, F., Russo, C. R., Bandinelli, S., Bartali, B., Cavazzini, C., Di Iorio, A., Corsi, A. M., Rantanen, T., Guralnik, J. M., & Ferrucci, L. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00246.2003 · Cited by 1,946 · cited 2×
“Criteria that have been proposed to identify or diagnose sarcopenia are the ratio of appendicular skeletal muscle mass relative to height (11) or the knee extension strength/torque, handgrip strength, or calf muscle area at least 2 SDs below the mean of a young reference group (12).”
BackgroundResultRommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583 · cited 1×
“IGF-1 stimulates protein synthesis via the mammalian target of rapamycin system (mTOR); (40), but muscle protein synthesis does differ little or not at all between fasted young and old males (15) and certainly not by the magnitude by which IGF-1 differs.”
BackgroundMyostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., & Harris, T. B. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m326 · Cited by 1,294
Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle
Cuthbertson, D., Smith, K., Babraj, J., Leese, G., Waddell, T., Atherton, P., Wackerhage, H., Taylor, P. M., & Rennie, M. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2640fje · Cited by 1,211 · cited 2×
“Second, muscle displays “anabolic resistance,” which is a decreased protein synthesis response to amino acids (15), insulin (16), and resistance exercise (17).”
BackgroundSelf-citationThe Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Muscle weakness and falls in older adults: a systematic review and meta-analysis
Moreland, J. D., Richardson, J. A., Goldsmith, C. H., & Clase, C. M. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52310.x · Cited by 988
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890
Sarcopenia: characteristics, mechanisms and functional significance
Narici, M. V., & Maffulli, N. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldq008 · Cited by 827
REGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819
Kumar, V., Selby, A., Rankin, D., Patel, R., Atherton, P., Hildebrandt, W., Williams, J., Smith, K., Seynnes, O., Hiscock, N., et al. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164483 · Cited by 740 · cited 1×
“Second, muscle displays “anabolic resistance,” which is a decreased protein synthesis response to amino acids (15), insulin (16), and resistance exercise (17).”
BackgroundGonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571 · cited 1×
“Myostatin-Related Serum Factors Earlier studies on serum myostatin in diseases with muscle atrophy have been considered unreliable (39) because of the antibodies and assays used (24).”
MethodNewman, A. B., Haggerty, C. L., Goodpaster, B., Harris, T., Kritchevsky, S., Nevitt, M., Miles, T. P., Visser, M., & The Health, A. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51105.x · Cited by 505
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
Wagner, K. R., Fleckenstein, J. L., Amato, A. A., Barohn, R. J., Bushby, K., Escolar, D. M., Flanigan, K. M., Pestronk, A., Tawil, R., Wolfe, G. I., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21338 · Cited by 481
Petrella, J. K., Kim, J.-S., Cross, J. M., Kosek, D. J., & Bamman, M. M. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00190.2006 · Cited by 356 · cited 2×
“IGF-1 concentrations are lower in elderly participants than in young (31,32), and in the Framingham heart study, higher IGF-1 concentrations were associated with a smaller loss of fat-free mass women (29).”
BackgroundResultQuadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling Pathways
Lee, S.-J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000789 · Cited by 316
Testosterone injection stimulates net protein synthesis but not tissue amino acid transport
Ferrando, A. A., Tipton, K. D., Doyle, D., Phillips, S. M., Cortiella, J., & Wolfe, R. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e864 · Cited by 256 · cited 1×
“Serum testosterone is often decreased in elderly men (33), and because testosterone increases muscle protein synthesis (34), the decline of free testosterone during ageing is a potential cause of sarcopenia.”
BackgroundPayette, H., Roubenoff, R., Jacques, P. F., Dinarello, C. A., Wilson, P. W. F., Abad, L. W., & Harris, T. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51407.x · Cited by 245 · cited 3×
“Higher concentrations of tumor necrosis factor a (TNFa) were associated with 5-year declines in muscle mass and grip strength (28), whereas interleukin-6 (IL-6) concentrations predicted sarcopenia in women (29).”
BackgroundResultWilkes, E. A., Selby, A. L., Atherton, P. J., Patel, R., Rankin, D., Smith, K., & Rennie, M. J. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27543 · Cited by 204
Sarcopenia: Clinical evaluation, biological markers and other evaluation tools
Pahor, M., Manini, T., & Cesari, M. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0204-9 · Cited by 200
Research works printed but not linked: 21
- Clark, 2008, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 63, 829, 10.1093/gerona/63.8.829 · DOI · Paper page
- 2002, J GERONTOL A BIOL SCI, 57, 144B, 10.1093/gerona/57.4.B144 · DOI · Paper page
- Rantanen, 1999, JAMA, 281, 558, 10.1001/jama.281.6.558 · DOI · Paper page
- Wolfe, 2006, The American Journal of Clinical Nutrition, 84, 475, 10.1093/ajcn/84.3.475 · DOI · Paper page
- 2008, BMJ, 337, 92
- 2010, Age and Ageing, 9, 412
- Lexell, 1988, Journal of the neurological sciences, 84, 275, 10.1016/0022-510X(88)90132-3 · DOI · Paper page
- 2006, The FASEB Journal, 10.1096/fj.05-4607fje · DOI · Paper page
- Carlson, 2009, 1, 381, 10.1002/emmm.200900045 · DOI · Paper page
- Zimmers, 2002, Science, 296, 1486, 10.1126/science.1069525 · DOI · Paper page
- Siriett, 2006, Journal of cellular physiology, 209, 866, 10.1002/jcp.20778 · DOI · Paper page
- Lakshman, 2009, Molecular and cellular endocrinology, 302, 26, 10.1016/j.mce.2008.12.019 · DOI
- 2003, Molecular Endocrinology, 17, 1144, 10.1210/me.2002-0366 · DOI · Paper page
- 2002, Journal of Biological Chemistry, 277, 40735, 10.1074/jbc.M206379200 · DOI · Paper page
- 2009, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 64, 1183
- Hameed, 2002, Exercise and sport sciences reviews, 30, 15, 10.1097/00003677-200201000-00004 · DOI · Paper page
- Amin, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 19, 1075, 10.1359/JBMR.040301 · DOI · Paper page
- 1998, American Journal of Physiology -- Legacy Content, 275, E864
- 2006, Journal of Applied Physiology, 100, 780, 10.1152/japplphysiol.00737.2005 · DOI · Paper page
- GREIG, 1994, Age and Ageing, 23, 185, 10.1093/ageing/23.3.185 · DOI · Paper page
- Streckis, 2007, Muscle & nerve, 36, 357, 10.1002/mus.20816 · doi:10.1002/mus.20816
Cited by
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797
Mitchell, W. K., Williams, J., Atherton, P., Larvin, M., Lund, J., & Narici, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00260 · Cited by 1,377
Wilkinson, D. J., Piasecki, M., & Atherton, P. J. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.005 · Cited by 874
Insulin resistance and sarcopenia: mechanistic links between common co-morbidities
Cleasby, M. E., Jamieson, P. M., & Atherton, P. J. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0533 · Cited by 596
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways
Rodriguez, J., Vernus, B., Chelh, I., Cassar-Malek, I., Gabillard, J. C., Hadj Sassi, A., Seiliez, I., Picard, B., & Bonnieu, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1689-x · Cited by 397
“Additionally, different studies comparing the muscle mass of humans with sarcopenia (age-related muscle loss), reported divergent results ranging from an inverse correlation between serum myostatin levels and loss of muscle mass [34], to no effect [35].”
Background
Metadata
- Authors
- Ratkevicius, A., Joyson, A., Selmer, I., Dhanani, T., Grierson, C., Tommasi, A. M., DeVries, A., Rauchhaus, P., Crowther, D., Alesci, S., Yaworsky, P., Gilbert, F., Redpath, T. W., Brady, J., Fearon, K. C. H., Reid, D. M., Greig, C. A., & Wackerhage, H.
- Venue
- The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-07
- Volume
- 66A
- Issue
- 6
- Pages
- 620-626
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2049946444
- Cited by
- 104
- References
- 22
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.